Specific interaction between chitosan and matrix metalloprotease 2 decreases the invasive activity of human melanoma...

Area of Science:

• Biochemistry
• Cancer Biology
• Materials Science

Background:

• Tumor invasion, a key step in metastasis, is critically dependent on matrix metalloprotease 2 (MMP2) in melanoma cells.
• Matrix metalloprotease 2 (MMP2) plays a significant role in the invasive capabilities of melanoma cells, making it a potential therapeutic target.

Purpose of the Study:

• To investigate the effect of chitosan on melanoma cell invasion and MMP2 activity.
• To elucidate the mechanism by which chitosan influences MMP2 function.
• To explore the potential of chitosan as an MMP2 inhibitor for cancer therapy.

Main Methods:

• Cell-based invasion assays were performed to assess melanoma cell invasiveness.
• MMP2 activity in cell supernatant was measured using colorimetric assays.
• Atomic force microscopy (AFM) was employed to visualize the interaction between MMP2 and chitosan.
• Affinity chromatography was utilized to determine the binding specificity between MMP2 and chitosan.

Main Results:

• Chitosan significantly attenuated the invasive activity of melanoma cells.
• Chitosan reduced MMP2 activity in the supernatant without affecting MMP2 expression levels, indicating a posttranscriptional effect.
• Atomic force microscopy confirmed a direct molecular interaction between MMP2 and chitosan, forming complexes.
• Affinity chromatography demonstrated high binding specificity of MMP2 to chitosan.
• Chitosan acts as a noncompetitive inhibitor of MMP2 activity.

Conclusions:

• Chitosan effectively inhibits melanoma cell invasion by targeting MMP2.
• The inhibitory effect of chitosan on MMP2 occurs post-transcriptionally, involving direct molecular interaction and noncompetitive inhibition.
• Chitosan shows promise as a novel MMP2 inhibitor for therapeutic applications in melanoma treatment.